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Myofibril based mechanical studies allow evaluation of sarcomeric protein function. We
describe a novel method of obtaining myofibrils from primary cardiomyocyte culture.
Adult rat ventricular myocytes (ARVMs) were obtained by enzymatic digestion and
maintained in serum free condition. ARVMs were homogenized in relaxing solution
(pCa 9.0) with 20% sucrose, and myofibril suspension was made. Myofibrils were
Ca2+-activated and relaxed at 15◦C. Results from ARVM myofibrils were compared
to myofibrils obtained from ventricular tissue skinned with Triton X-100. At maximal
Ca2+-activation (pCa 4.5) myofibril mechanical parameters from ARVMs were 6.8 ± 0.9
mN/mm2 (resting tension), 146.8 ± 13.8 mN/mm2 (maximal active tension, P0), 5.4
± 0.22 s−1 (rate of force activation), 53.4 ± 4.4ms (linear relaxation duration), 0.69
± 0.36 s−1 (linear relaxation rate), and 10.8 ± 1.3 s−1 (exponential relaxation rate).
Force-pCa curves were constructed from Triton skinned tissue, ARVM culture day 1,
and ARVM culture day 3 myofibrils, and pCa50 were 5.79 ± 0.01, 5.69 ± 0.01, and
5.71 ± 0.01, respectively. Mechanical parameters from myofibrils isolated from ARVMs
treated with phenylephrine were compared to myofibrils isolated from time-matched
non-treated ARVMs. Phenylephrine treatment did not change the kinetics of activation
or relaxation but decreased the pCa50 to 5.56 ± 0.03 (vehicle treated control: 5.67
± 0.03). For determination of protein expression and post-translational modifications,
myofibril slurry was re-suspended and resolved for immunoblotting and protein staining.
Troponin I phosphorylation was significantly increased at serine 23/24 in phenylephrine
treated group. Myofibrils obtained from ARVMs are a viable method to study myofibril
mechanics. Phenylephrine treatment led to significant decrease in Ca2+-sensitivity that
is due to increased phosphorylation of TnI at serine 23/24. This culture based approach
to obtaining myofibrils will allow pharmacological and genetic manipulation of the
cardiomyocytes to correlate biochemical and biophysical properties.
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INTRODUCTION
Since its development, myofibril mechanical assessment has
led to advances in understanding of muscle function (1–4).
Myofibril-based mechanical assays, compared to studies using
larger preparations, offer several advantages. First, as the smallest
ensemble of muscle motor proteins, myofibril mechanical
experiments provide an evaluation of muscle mechanics without
influence by non-motor protein systems such as those involved
in calcium handling, energy metabolism, and the extracellular
matrix. Second, the level of detail which myofibril mechanical
experiments provide, such as resolution of the two phases of
cardiac muscle fiber relaxation, is not possible with skinned
cardiac fiber or intact cardiomyocyte preparations.
Traditionally, myofibrils are obtained from a small section of
muscle that is either glycerinated or skinned in Triton X-100
and homogenized (5, 6). A major limitation of this approach
is that these myofibrils are “as-is” with limited potential for
biochemical manipulations. In this regard, specifically targeting a
particular signaling pathway can only be achieved by generating
transgenic animals, which is time-intensive and costly. The
major strength of cardiomyocyte culture-based experiments is
the ability to utilize readily available reagents and tools to address
themyofilamentmechanical consequences of altering a particular
cellular function. Furthermore, with rapid advancement in stem
cell-derived cellular systems, an in vitro method of obtaining
myofibrils will provide a powerful experimental platform to
better understand the pathobiology of diseases involving striated
muscle. In this paper, we report a novel method of obtaining
myofibrils from primary adult rat ventricular myocyte (ARVM)
culture. We show that myofibrils obtained from primary ARVMs
are equivalent to the traditional method and show applicability
of this method to dissect the functional consequences of
manipulating a specific signaling cascade.
METHODS
Experimental Protocol
Adult rat left ventricular myocytes (ARVMs) were obtained
from female Sprague Dawley rats (250–300 g) (7). Animal
studies were reviewed and approved by University of Florence
and University of Colorado Institutional Animal Care and
Use Committee (IACUC) thereby meeting the standards set
by the Directive 2010/63/EU of the European Parliament
on the protection of animals used for scientific purposes
and the NIH standards for the care and use of laboratory
animals. The heart was rapidly removed and retrograde
perfused with perfusion buffer (120.5mM NaCl, 14.7mM
KCl, 0.6mM KH2PO4, 0.6mM Na2HPO4, 1.2mM MgSO4,
4.6mM NaHCO3, 10mM Na-HEPES, 30mM Taurine, 10mM
2,3-butanedione monoxime, 5.5mM Glucose, pH 7.2) for
10min at 37◦C. A small section of the left ventricular
apex was cut at the end of the pre-digestion perfusion.
The small apical tissue was skinned in Triton X-100. The
remainder of the heart was enzymatically digested to make
ARVMs (Figure 1).
Cardiomyocyte Culture
The heart was digested with Liberase DH (Roche, 0.33 mg/ml)
for 8min, cut into small pieces, and a slurry was filtered through
sterile 150-nm mesh. The filtrate was centrifuged at 400 g for
4min to separate myocytes from non-myocytes. The myocyte
suspension was layered over 60µg/ml of BSA and allowed
to settle for 15min to separate myocytes from non-myocytes.
Myocyte concentration was determined and plated on 100mm
laminin-coated plastic culture dishes at a density of 100 to
150 cells/mm2. The ARVM culture was maintained in serum-
free DMEM supplemented with albumin (2 mg/ml), carnitine
(2 mmol/l), creatine (5 mmol/l), taurine (5 mmol/l), BDM (1
mg/ml), and penicillin-streptomycin (100µg/ml).
Myofibrils From Cardiomyocyte Culture
ARVMs were washed in sterile PBS (room temperature) twice
then collected one of two ways. (1) The cells were collected in
1ml of cold 20% sucrose in relaxing solution (pCa 9.0) with
protease inhibitor cocktail (10µM leupeptin, 5µM pepstatin,
200µM phenyl-methylsuphonylfluoride, 10µM E64, 500µM
NaN3, 2mM dithioerythritol). The demembraned ARVM slurry
was vortexed (30 s then settled on ice for 10min. The cell
suspension was centrifuged (300 g for 15min in 4◦C) and the
pellet was resuspended in fresh relaxing solution with protease
inhibitor cocktail to remove the sucrose. The resuspension/wash
cycle was repeated twice. The final demembraned ARVMs were
resuspended in relaxing solution with protease inhibitor cocktail
and homogenized at medium speed (Tissue Tearer) for 15–20 s
to make the final myofibril suspension. (2). Cells were collected
in 1ml of cold 0.01% Triton-X in relaxing solution (pCa9.0)
with protease inhibitor cocktail. The ARVM slurry was treated
as described above.
Myofibrils From Apical Tissue
The left ventricular apex was cut into thin slices and bathed
in 0.05% Triton X-100 and protease inhibitor cocktail in rigor
solution overnight at 4◦C. The skinned tissue was then washed
twice in rigor solution with protease inhibitor cocktail with
gentle shaking. The skinned tissue was resuspended in 1ml
rigor solution with protease inhibitor cocktail and homogenized
at medium speed for 15–20 s to make the final myofibril
suspension (8, 9).
Myofibril Mechanical Study
We used previously published techniques to measure and control
the force and length of isolated myofibrils activated and relaxed
by fast solution switching (8, 9). Briefly, a small volume of
myofibril suspension was transferred to a temperature controlled
chamber (15◦C) filled with relaxing solution (pCa 9.0). A small
bundle of myofibrils were mounted between two microtools.
One tool was connected to a motor that could produce rapid
length changes (Mad City Labs). The second tool was a calibrated
cantilevered force probe (4–8 µm/µN; frequency response 2–
5KHz). Myofibrils were set 5–10% above slack myofibril length
in relaxed conditions (pCa 9). Average sarcomere length and
myofibril diameter were measured using ImageJ. Mounted
myofibrils were activated and relaxed by rapidly translating the
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FIGURE 1 | (A) Experimental scheme: hearts from Sprague Dawley rats are retrograde perfused. Before enzymatic digestion, a small section of the apex is cut to
obtain myofibrils by skinning in Triton-X100. Remaining heart was digested in Liberase DH to obtained primary ARVM culture. Myofibrils from ARVM culture were
obtained by sucrose based osmotic shock method. (B) Representative images of 10x magnification demonstrating the different quantity and quality of myofibrils
isolated using the different techniques. Black arrows indicate useable myofibrils in each field. The myocyte fragments shown in the panel of ARVMs harvested using
Triton-x show a morphology distinct from the fragments of the other harvest techniques. (C) Representative image of a myofibril isolated from ARVMs using the
sucrose-based method. (D) Representative trace from an ARMV-derived myofibril activated and relaxed by fast solution switching. ARVM, adult rat ventricular
myocyte.
interface between two flowing streams of solutions of different
pCa (9, 10). Data was collected and analyzed using a customized
LabView software. Measured mechanical and kinetic parameters
were defined as follows: resting tension (mN/mm2)—myofibril
basal tension in fully relaxing condition (pCa 9.0); maximal
tension (mN/mm2)—maximal tension generated at full calcium
activation (pCa 4.5); the rate constant of tension development
following maximal calcium activation (kACT); the rate constant
of tension redevelopment following a release-restretch applied
to the activated myofibril (kTR) (11); rate constant of early slow
force decline (slow kREL)—the slope of the linear regression
normalized to the amplitude of relaxation transient, duration
of early slow force decline—measured from onset of solution
change to the beginning of the exponential force decay, the rate
constant of the final exponential phase of force decline (fast kREL).
To determine force-pCa relationship, peak isometric force was
recorded at maximal (pCa 4.5) and submaximal (pCa 5.2, 5.4,
5.6, 5.8, 7) calcium concentrations and fitted to the Hill equation
(P/P0= 1/(1+10(−nh(pCa50−pCa))).
Myofilament Protein Analysis
To determine the level of phosphorylated myofilament proteins,
the myofibril slurry was spun down and protein pellet was
resuspended in isoelectric focusing buffer (IEF; 8M Urea,
2.5M Thiourea, 4% Chaps, 2mM EDTA, 1mM DTT, 1%
TBP, phosphatase, and protease inhibitors). Twenty micrograms
of protein was resolved by SDS-PAGE using a 10% gel
and stained with ProQ Diamond. The gel was washed in
methanol and restained with commassie brilliant blue (CBB)
to determine total protein abundance. Gels were scanned and
densitometry was measured using ImageJ. To determine the
site-specific phosphorylation of troponin I, Western blots were
performed. Site specific phospho-antibodies directed to serine
23/24 (Phosphosolutions p2010–2324, 1:1,000) and serine 43/44
(Phosphosolutions 9056, 1:1,000) of troponin I were used for
Western blotting. TnI antibody (Fitzgerald 10R-T123K, 1:1,000)
was used to determine the relative abundance of phosphorylated
proteins. Densitometry data was used to normalize the phospho-
specific signal over the total TnI signal.
Statistical Analysis
Statistical analyses were performed using Prism Version 6
(GraphPad Software, San Diego, CA). Mean ± SEM values are
presented. Data were checked for normality by Shapiro-Wilks test
and if normal, compared by Student t-test (2 unpaired groups) or
one-way ANOVA (>2 groups) with Newman-Keuls post-test. If
not normal, data were log-transformed before statistical testing.
Probability values of p < 0.05 were considered significant.
RESULTS
Myofibrils From Cultured Cardiomyocytes
Permeabilized Using Sucrose Are Viable
Our initial aim was to determine the cardiomyocyte skinning
buffer and homogenization protocol to harvest myofibrils from
ARVMs. We began with low concentrations of Triton X-100 in
rigor or relaxing solutions. 0.1% Triton X-100 caused complete
lysis of cardiomyocytes in either buffer. We were able to harvest
myofibrils from cardiomyocytes skinned in 0.01% Triton X-
100 in rigor solutions but yielded poor quality and lower
quantity of myofibrils. These myofibrils tended to be shorter,
more fragmented, and difficult to mount on our force recording
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machine (Figure 1B). Sucrose (20% by volume) in relaxing
solution was able to disrupt the cellular membrane without
affecting the integrity of the myofibrils (Figures 1B–D).
Mechanical Parameters From Myofibrils
From ARVM Are Comparable to the
Mechanical Parameters From Myofibrils
From Tissue
Next mechanical parameters of myofibrils from ARVM culture
harvested with sucrose or frozen tissue were compared.
Myofibrils were isolated from frozen rat LV as a comparison
since this is the standard source of myofibrils used to assess
disease-specific differences in human hearts or animal models.
The isometric sarcomere length measured was similar. The
TABLE 1 | Comparison of mechanical parameters between myofibrils obtained
from ARVM culture vs. traditional small tissue section.
ARVM (N, n) Tissue (N, n) P
Sarcomere length (µm) 2.24 ± 0.09 (6, 19) 2.28 ± 0.07 (6, 15) ns
Resting tension (mN/mm2 ) 6.8 ± 3.5 (6, 17) 6.6 ± 3.8 (6, 13) ns
Maximal tension (mN /mm2 ) 146.8 ± 51.7 (6, 14) 139.6 ± 51.3 (6, 15) ns
KACT (s
−1 ) 5.37 ± 0.95 (6, 18) 4.97 ± 1.14 (6, 14) ns
KTR (s
−1 ) 5.20 ± 0.89 (6, 17) 4.52 ± 0.82 (6, 15) p < 0.05
Linear relaxation duration (ms) 53.4 ± 17.7 (6, 16) 52.0 ± 16.2 (6, 12) ns
Exponential relaxation rate (s−1 ) 10.8 ± 4.8 (6, 14) 14.6 ± 6.5 (6, 12) ns
Myofibrils are fully calcium activated (pCa 4.5) and fully relaxed (pCa 9) by fast solution
switching. Data presented with mean ± SEM. (N,n), (N# of rats, n # of myofibrils).
mechanical and kinetic behavior of ARVM myofibrils was not
statistically different from tissue-derived myofibrils for most
parameters (Table 1). The kinetics of force redevelopment (kTR)
were, however, slower in myofibrils from tissue. Mechanical run-
down, the decrement of force generation, and its kinetics with
successive activation-relaxation cycles was comparable between
myofibrils isolated from ARVMs and tissue (data not shown).
Force-pCa curves were constructed from myofibrils obtained
from ARVMs in culture or from tissue. Ca2+-sensitivity and
the Hill coefficients (nH) were similar between myofibrils from
ARVM and tissue (Figure 2A).
Duration of Cultured Cells Affects Kinetics
of Activation and Relaxation but Not
Calcium Sensitivity
In order to understand how prolonged culture affects the
mechanical properties of cardiac myofibrils, we compared
myofibrils isolated using sucrose from cardiomyocyte culture at
day 1 and day 3. Myofibrils from day 1 group were isolated
from cardiomyocytes that were kept in serum-free media in a
37◦C incubator between 2 and 8 h. The 3-day-old cardiomyocytes
were kept in a serum-free culture environment for an additional
48 h. Although magnitude of tension generation was unaffected
by long-term culture, 3 days of culture showed changes in
kinetics of activation and relaxation (Table 2). Using Pro-Q
Diamond staining to assess for phosphorylation of sarcomeric
proteins, we did not see a significant change in the degree of
phosphorylation of key contractile and regulatory proteins of the
FIGURE 2 | (A) Force-pCa relationship of myofibrils obtained from cardiomyocyte culture day 1 (blue), culture day 3 (red) vs. myofibrils isolated from cardiac tissue
(black). At each pCa, maximal tension was normalized to tension generated at pCa 4.5 (P0). Data points are mean ± SEM. Lines are drawn according to the
parameters estimated by fitting to the Hill equation (P/ P0 = 1/)(1 +10
(−nh(pCa50−pCa))). N = 4 rats, 16–20 myofibrils. (B) Force-pCa relationship of myofibrils
obtained from ARVMs that were PE-treated (black), myofibrils treated with PE and the β-blocker propranolol (BB) (red) vs. vehicle treated control (blue). N = 6 rats,
16–22 myofibrils. ARVM, adult rat ventricular myocyte; PE, phenylephrine; BB, β-blocker propranolol.
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TABLE 2 | Comparison of mechanical parameters between myofibrils obtained
from ARVMs cultured for 1 day and ARVMs maintained in serum-free medium for
3 days.
ARVM Day 1 (N, n) ARVM Day 3 (N, n) P
Sarcomere length (µm) 2.24 ± 0.09 (6, 19) 2.25 ± 0.07 (8, 9) ns
Resting tension (mN/mm2 ) 6.8 ± 3.5 (6, 17) 7.3 ± 3.2 (8, 19) ns
Maximal tension (mN /mm2 ) 146.8 ± 51.7 (6, 14) 135.8 ± 47.6 (8, 18) ns
KACT (s
−1 ) 5.37 ± 0.95 (6, 18) 4.05 ± 0.98 (8, 19) P < 0.05
KTR (s
−1 ) 5.20 ± 0.89 (6, 17) 4.90 ± 0.95 (8, 19) ns
Linear relaxation duration (ms) 53.4 ± 17.7 (6, 16) 34.2 ± 8.5 (8, 14) P < 0.05
Exponential relaxation rate (s−1 ) 10.8 ± 4.8 (6, 14) 10.2 ± 5.2 (8, 16) ns
Myofibrils are fully calcium activated (pCa 4.5) and fully relaxed (pCa 9) by fast solution
switching. Data presented with mean ± SEM.
sarcomere (Figure 3). The duration that ARVMs were kept in
primary culture had no impact on Ca2+-sensitivity or the Hill
coefficient (Figure 2A).
Treating ARVMs With Phenylephrine Leads
to Decreased Calcium Sensitivity in
Myofibrils Due to Phosphorylation of
Troponin I
To demonstrate the applicability of culture based cardiomyocyte
myofibrils to study the effect of manipulating the adrenergic
signaling pathway, we treated ARVMs with phenylephrine
(PE; 20µM) for 48 h and performed myofibril mechanical
measurements and sarcomeric protein analysis. Myofibrils were
harvested using the sucrose method. We and others have shown
that prolonged PE treatment leads to significant cardiomyocyte
hypertrophy, induction of the pathologic gene profile, and
deterioration of intact cardiomyocyte function (12, 13). The
kinetics of activation and relaxation, and tension generation
were unchanged with PE treatment (Table 3). Treatment with PE
led to a significant decrease in calcium sensitivity (Figure 2B).
Using CBB protein staining, we did not see a change in the
expression level of sarcomeric proteins between vehicle vs.
PE treated ARVMs (Figure 3). Global phosphorylation status
was examined using Pro-Q Diamond stain. PE treatment led
to increased phosphorylation of troponin I (TnI) (Figure 3).
Western blot analysis confirmed the change in phosphorylation
of serine 23/24 while serine 44 was not affected (Figure 4A).
Decreased calcium sensitivity due to phosphorylation of TnI
at serine 23/24 is consistent with previously published studies.
To confirm our hypothesis that PE was also activating PKA
via β-adrenergic signaling pathway, we treated ARVMs with PE
with or without propranolol (2µM). Propranolol treatment was
sufficient to inhibit the increased phosphorylation of Serine 23/24
TnI (Figure 4) and the shift in pCa50 (Figure 2B). Propranolol
treatment alone did not have any effect in basal expression of TnI
or phosphorylation (Figure 4).
DISCUSSION
We report a novel method of obtaining myofibrils from cultured
ARVMswhich are suitable for myofibril mechanical experiments.
We establish that myofibrils obtained from an ARVM culture
system are equivalent in mechanical properties to myofibrils
prepared by skinning small cardiac tissue with Triton-X100.
Demonstrating applicability of this method, we show that PE
treatment does not significantly affect activation kinetics and
tension generation, but PE treatment increases phosphorylation
of TnI contributing to decreased myofilament calcium sensitivity
when compared to vehicle treated controls. These findings
show that primary ARVM culture system can be used for
myofibril mechanical studies, and will expand the utility of
myofibril mechanical experiment by providing a wider palette of
experimental conditions.
The major advantage of myofibrils obtained from a primary
culture system over the traditional Triton X-100 method is that
primary culture system allows manipulation of specific cellular
processes using widely available experimental techniques. The
traditional method of obtaining myofibrils from a small heart
section can be viewed as “as-is” with limited potential for ex-
vivo manipulation. The combination of myofibril mechanical
experiments and the wide array of biochemical techniques
available to manipulate cultured cells provides a flexible
experimental system to study the mechanical consequences of
altering a specific cellular function. ARVM based myofibril
studies provides additional advantages. ARVM are relatively
inexpensive when compared to the need for generating mutant
animals. For example, if you consider a potential experiment
studying how protein x impacts myofibril mechanics, the cost
and time to generate a transgenic or knockout animal is
roughly $7,000 and can take up to 14 weeks. From there,
there are costs associated with breeding and maintenance of
a colony where animal costs can exceed $250 a month not
including the salary of the staff necessary to oversee the colony.
This total quickly reaches $10,000 or more and takes at least
6 months. In contrast, consider purchasing 6 adult rats at
roughly $50 each and generating ARVMs. From here, the
cells can be treated with inhibitors or ectopically expressed
proteins and myofibril mechanics studied. On a practical level,
we found that homogenizing intact cardiomyocytes to small
bundles of myofibrils was easier to achieve from ARVMs
than from small cardiac tissue. Our ARVM based method
is complementary to the current standard and provides an
additional source of experimental material. Importantly, our
results show that myofibrils from ARVMs are mechanically
comparable to myofibrils derived from tissue.
One difference in mechanical properties that we noted
between tissue and ARVMs harvested using sucrose was that
kTR was faster in ARVMs. This difference could be due to
structural changes in the sarcomeres that occur following
plating (14, 15) or it may be an experimental difference in
isolation techniques (Triton X-100 compared to sucrose). It is
important to recognize that these factors affect the mechanical
parameters and experimental conditions should be considered
appropriately. To further explore how plating impacts sarcomere
function, we determined how duration of primary culture
impacts myofibril function. Cardiomyocytes have been found to
undergo transformation when maintained in primary culture.
Although maintaining cardiomyocytes for up to 15 days has
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FIGURE 3 | (A) Myofilament protein phosphorylation from ARVMs treated with PE for 2 and 48 h. ProQ Diamond® stain (PQD) was used to determine the global
phosphorylation status of myofilament proteins. The same gel was stained with commassie brilliant blue (CBB) to determine relative abundance of proteins.
(B) Quantification of PQD over CBB densitometries. Only those sarcomeric proteins with significant change in global phosphorylation are shown. Phosphorylation of
TnI is significantly increased in ARVMs after 2 h (p < 0.0001) and 48 h (p = 0.003) of PE treatment. Myosin binding protein C (MyBP-C) trends to increased
phosphorylation at 48 h of treatment (p = 0.056) but not at 2 h. N = 5 rats. ARVM, adult rat ventricular myocyte; PE, phenylephrine; CBB, commassie brilliant blue;
TnI, troponin I; MyBP-C, myosin binding protein C.
TABLE 3 | Comparison of mechanical parameters between myofibrils from
ARVMs treated with PE for 48 h.
Vehicle (N, n) PE (N, n) P
Sarcomere length
(µm)
2.21 ± 0.1 (6, 19) 2.21 ± 0.1 (6, 22) ns
Resting tension
(mN /mm2 )
7.6 ± 2.8 (6, 18) 6.7 ± 2.5 (6, 17) ns
Maximal Tension
(mN /mm2 )
135.8 ± 47.6 (6, 17) 118.8 ± 38.6 (6, 17) ns
KACT (s
−1) 4.05 ± 0.98 (6, 19) 3.95 ± 0.94 (6, 19) ns
KTR (s
−1) 4.90 ± 0.95 (6, 19) 4.37 ± 1.02 (6, 19) P = 0.059
Linear Relaxation
Duration (ms)
34.2 ± 8.5 (6, 15) 43.8 ± 17.1 (6, 15) ns
Linear Relaxation Rate (s−1) 1.27 ± 0.91 (6, 6) 1.35 ± 0.65 (6, 8) ns
Exponential Relaxation
Rate (s−1)
9.04 ± 3.3 (6, 15) 10.0 ± 5.1 (6, 19) ns
Myofibrils are fully calcium activated (pCa 4.5) and fully relaxed (pCa 9) by fast solution
switching. Data presented with mean ± SEM. (N,n), (N# of rats, n # of myofibrils).
been described (15), we and other investigators report an optimal
culture time frame of up to 5–8 days (7). It is believed that the
limited life-span of ARVMs in culture is due to dedifferentiation.
Eppenberger et al. (16) demonstrated that over time cultured
ARVMs have extensive morphological changes so that they
look more like fetal myofibril and therefore achieve a less
differentiated state (16). Dedifferentiation of cardiomyocytes in
long-term culture is inevitable, but serum-free culture media
decreases the rate of dedifferentiation (14). The culture media is
critical to maintain healthy cells, and the culture media additives
for ARVMs are albumin, creatine, carnitine, taurine, BDM,
penicillin, and streptomycin. We have set 5 days as the upper
limit for maintaining ARVMs in culture, and have designed
our experiments around this time frame. We and others have
previously shown and show additional data in this report that
key functional and regulatory proteins of the sarcomere are
unchanged in the level of expression and modification (12, 13,
17). The half-life of sarcomeric proteins ranges between 3 and
10 days (18, 19). Our data shows that there is no significant
change in the expression level or global phosphorylation of
sarcomeric proteins obtained from ARVMs in short vs. long term
culture. Although we do not report qualitative or quantitative
changes of sarcomeric proteins, we report significant changes in
activation and relaxation kinetics between day 1 and day 3. This
degree of change in biomechanical properties is not unexpected
considering that ARVMs in primary culture are dedifferentiating.
We hypothesize that routine biochemical assays used in this
study to evaluate for the abundance and the post-translational
modification status of sarcomeric proteins are not sensitive
enough to detect subtle changes. These small changes appear
to be sufficient to exert significant change in myofilament
function. In this regard, experiments that compare myofibril
mechanics between freshly isolated ARVM to one that is several
days old would be inappropriate. In our experimental protocol,
treated groups are always compared to age-matched vehicle
treated controls, thereby allowing us to evaluate the effects of
the treatment group while taking into account the unavoidable
changes that are inherent in a primary culture based experiment.
Adult rat ventricular cardiomyocytes treated with PE (20µM)
for 48 h demonstrate that TnI phosphorylation is an important
effector of sarcomeric protein function. Previously, we and
others have shown that treating ARVMs with 48 h of PE
caused contractile dysfunction (7, 13). This report builds
on the previous study and provides new data showing that
cardiomyocyte dysfunction does not require dysfunction of
myofibril contractile machinery. This observation suggests a
hierarchy of cardiomyocyte dysfunction by showing that the
contractile machinery remains capable even in the face of
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FIGURE 4 | (A) Representative Western blot demonstrating serine 23/24 is
preferentially phosphorylated with PE treatment. Each lane is protein isolated
from different experiments. These conditions were repeated in ARVMs cultured
from 5 different rat hearts. (B) Representative image of a Western blot showing
pre-treatment of ARVMs with the β-blocker propranolol (BB) leadsto inhibition
of TnI phosphorylation at serine 23/24. Experiment was repeated in ARVMs
cultured from 3 different rat hearts. (C) Quantification of TnI serine 23/24
phosphorylation normalized to total TnI. PE significantly increases
phosphorylation of TnI at Ser 23/24 (p < 0.001). Treatment with PE and a
β-blocker (BB) propranolol, normalizes TnI phosphorylation (PE tx v PE+BB
p < 0.001). Each lane is protein isolated from different experiments. These
conditions were repeated in ARVMs cultured from 3 different rat hearts. TnI,
troponin I; PE, phenylephrine; ARVM, adult rat ventricular myocyte; BB,
β-blocker propranolol.
cellular dysfunction. If the basic contractile unit from a
dysfunctional cardiomyocyte is functioning normally, then can
we target the basic contractile unit to normalize the whole
cell function? We have previously published data showing
that targeted inhibition of histone deacetylase 6 can augment
contractility of myofibrils to normalize whole heart function
in an angiotensin model of rodent heart failure (20). This
strategy of targeting the myofibril to augment inotrope may
offer benefits over currently available agents such as dobutamine
or milrinone which targets the upstream receptor or enzymatic
cascade immediately below the receptor. Clinical data may
support this hypothesis since in adult heart failure literature,
prolonged use of dobutamine or milrinone, while having
positive inotropic effects, leads to increased mortality from
side effects (21, 22). If our observation can be applied
to human heart failure, perhaps targeting the myofibrillar
proteins directly may provide a more direct and less toxic
inotropic support.
We also report that PE, an α-adrengeric and β-adrenergic
agonist (23), modifies TnI at serine 23/24. TnI serine 23/24 is
predominantly under the control of protein kinase A (PKA),
the down-stream effector of β-adrenergic receptor cascade. This
observation provides insight into the role of PKA in modulating
troponin I phosphorylation, the kinetics of cross-bridge cycle,
and calcium sensitivity of cardiac myofibrils. We show that
increased phosphorylation of serine 23/24 TnI decreases the
calcium sensitivity without affecting the kinetics of activation
or relaxation. Our results are in agreement with previous
work performed in human myofibrils treated with PKA (24).
Others, using rodent myofibrils, showed that activation of PKA
resulted in both right shift in calcium sensitivity and changes
in activation and relaxation kinetics (25, 26). Specifically, Rao
et al. (25) exchanged TnI with targeted mutations in serine 23/24
into myofibrils to illustrate that phosphorylation status of TnI
can control both relaxation duration and calcium sensitivity
of activation. While both studies show the regulatory role of
serine 23/24 in calcium sensitivity of activation, PE treatment
of ARVMs leads to different results in relaxation kinetics. This
difference may be due to the experimental condition. In our
experiment, we stimulated cardiomyocytes with an upstream
agonist thereby activating myriad of other secondary effectors.
In Rao’s work, exchanging mutant TnI into myofibrils would
avoid the effects of signaling cascade that results from receptor
activation (25). Regardless of the experimental protocol, we are in
agreement that serine 23/24 is an important effector in changing
sensitivity to calcium activation. Additional conclusions about
the role of serine 23/24 in regulating relaxation remains, however,
unsettled. The ability to obtain viable myofibrils from ARVMs
presents an opportunity to use established myofibril mechanical
assays in an in vitromodel system which will be a valuable tool to
inform mechanisms driving mechanical alterations.
In conclusion, we report that myofibrils obtained from
ARVM culture are similar in mechanical properties to myofibrils
isolated by skinningsmall sections of heart tissue.. While the
traditional method of Triton X-100 based myofibrils will remain
germane to myofibril mechanical research, we are confident
that the primary ARVM culture based myofibrils will prove to
be a powerful research tool complementing the time proven
traditional method.
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